Tag: Oncology

Latest News

Osaka University and Fuzionaire Radioisotope Technologies K.K. to Jointly Develop Astatine-211 Radiopharmaceuticals and Fluorine-18 Radiotracers for Oncology

Newsemia
TOKYO & OSAKA, Japan–(BUSINESS WIRE)–Fuzionaire Radioisotope Technologies K.K. (“FRIT”), a Japanese affiliate of radiopharmaceutical company Fuzionaire Diagnostics, Inc. (“Fuzionaire Dx”), today announced a collaborative research...
Latest News

Immunotherapy more effective than chemotherapy for children, young adults with relapsed B-ALL

Newsemia
New findings from a clinical trial show that treatment with the immunotherapy drug blinatumomab is superior to standard chemotherapy for children and young adults with...
Latest News

Researchers confirm two new prognostic markers for triple negative breast cancer

Newsemia
Physicians who treat patients with triple negative breast cancer have two new ways to predict which patients may benefit most from the well-established post-surgery treatment...
Latest News

Streamlining Immuno-Oncological Therapeutic Antibody Discovery

Newsemia
The growing trend of implementing immunotherapy into oncology has resulted in various new therapeutic cancer treatments utilizing antibodies. Source link...
Latest News

Breast-conserving treatment may be a viable alternative to mastectomy, study suggests

Newsemia
Approximately 10% of breast cancer patients treated with lumpectomy (breast-conserving surgery [BCS]) and whole-breast radiation (WBI) will have a subsequent in-breast local recurrence of cancer...
Latest News

Biosimilar for HER2+ breast cancer achieves similar overall response rate to reference drug

Newsemia
The trastuzumab biosimilar HLX02 achieved similar overall response rate to reference trastuzumab in women with human epidermal growth factor receptor 2-positive (HER2+) recurrent or previously...
Gastroenterology

Combination therapy improves survival in patients with hepatocellular carcinoma

Newsemia
Combination therapy with the PD-L1 inhibitor atezolizumab and the VEGF inhibitor bevacizumab significantly improves overall survival and progression-free survival in patients with unresectable hepatocellular carcinoma...
Latest News

Clovis Oncology kündigt Erstattung für Rubraca®-Tabletten (Rucaparib) für Frauen mit rezidivierendem Eierstockkrebs in Italien an

Newsemia
BOULDER, Colorado–(BUSINESS WIRE)–Clovis Oncology, Inc. (NASDAQ: CLVS), hat heute bekannt gegeben, dass die italienische Arzneimittelagentur AIFA die Erstattung von Rucaparib in Italien zugelassen hat. Rucaparib...
Surgery/Cosmetic

Residents entering Complex General Surgical Oncology fellowship lack confidence with pelvic MRI for rectal cancer: Results of a needs assessment survey

Newsemia
Magnetic resonance imaging (MRI) is essential for the multidisciplinary treatment of rectal cancer. However, baseline experience of surgical residents with MRI is unknown. Therefore, a...
Gastroenterology

HIMC at Mount Sinai to evaluate therapeutic effects of novel cancer immunotherapy

Newsemia
The Human Immune Monitoring Center at the Icahn School of Medicine at Mount Sinai will apply cutting-edge high-throughput technologies to evaluate the therapeutic effects of...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy